1 completed, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cytran: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer carboplatin, oglufanide disodium, paclitaxel - Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | Unknown | Cytran | 2001-01-01 | 2013-11-06 | |
| Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients IM862 - Sarcoma, Kaposi, HIV Infections | Phase 3 | Completed | Cytran | 200 | 2005-06-24 |
AIDS-Related Opportunistic Infections (1) · Brenner Tumor (1) · Carcinoma, Ovarian Epithelial (1) · HIV Infections (1) · Ovarian Neoplasms (1) · Sarcoma, Kaposi (1)
Carboplatin (1) · Paclitaxel (1)
United States (2) · Australia (1) · Belgium (1) · Canada (1)
Ariela Noy (1) · David Scadden (1) · Pamela Paley, MD (1) · Parkash Gill (1)